Moleculin expects first pivotal trial data readout in Q1 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. ADI
6. MRK
7. MRNA
8. TJX
9. DE
10. LOW

Go back to Moleculin expects first pivotal trial data readout in Q1 2026
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.63 +0.06 (10.53%)
Previous Close $0.57    52 Week High $9.58 
Open $0.58    52 Week Low $2.34 
Day High $0.64    P/E N/A 
Day Low $0.55    EPS $-0.34 
Volume 646,355